MEP6808A - Priperidinoilpirodolini agonisti receptora menalokortina tipa 4 - Google Patents

Priperidinoilpirodolini agonisti receptora menalokortina tipa 4

Info

Publication number
MEP6808A
MEP6808A MEP-68/08A MEP6808A MEP6808A ME P6808 A MEP6808 A ME P6808A ME P6808 A MEP6808 A ME P6808A ME P6808 A MEP6808 A ME P6808A
Authority
ME
Montenegro
Prior art keywords
piperidinoylpyrrolidines
receptor agonist
melanocortin
melanocortin type
type
Prior art date
Application number
MEP-68/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Anette Graven Sams
Mogens Larsen
Gitte Mikkelsen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of MEP6808A publication Critical patent/MEP6808A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MEP-68/08A 2006-02-23 2007-02-19 Priperidinoilpirodolini agonisti receptora menalokortina tipa 4 MEP6808A (xx)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77629506P 2006-02-23 2006-02-23
US88784007P 2007-02-02 2007-02-02
PCT/IB2007/000456 WO2007096763A2 (en) 2006-02-23 2007-02-19 Melanocortin type 4 receptor agonist piperidinoylpyrrolidines

Publications (1)

Publication Number Publication Date
MEP6808A true MEP6808A (xx) 2010-02-10

Family

ID=38169450

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-68/08A MEP6808A (xx) 2006-02-23 2007-02-19 Priperidinoilpirodolini agonisti receptora menalokortina tipa 4

Country Status (21)

Country Link
US (1) US8138188B2 (de)
EP (1) EP1989196B1 (de)
KR (1) KR101036981B1 (de)
AP (1) AP2008004602A0 (de)
AU (1) AU2007219236B2 (de)
BR (1) BRPI0708264A2 (de)
CA (1) CA2642922C (de)
CR (1) CR10219A (de)
DK (1) DK1989196T3 (de)
EA (1) EA200801738A1 (de)
EC (1) ECSP088688A (de)
ES (1) ES2402581T3 (de)
IL (1) IL193279A (de)
MA (1) MA30228B1 (de)
ME (1) MEP6808A (de)
MX (1) MX2008010899A (de)
NO (1) NO20083480L (de)
RS (1) RS20080371A (de)
SG (1) SG185849A1 (de)
TN (1) TNSN08337A1 (de)
WO (1) WO2007096763A2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2019100A1 (de) * 2007-07-19 2009-01-28 Santhera Pharmaceuticals (Schweiz) AG Substituierte Heteroarylpiperidinderivate als Melanocortin-4-Rezeptormodulatoren
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US8902867B2 (en) 2007-11-16 2014-12-02 Qualcomm Incorporated Favoring access points in wireless communications
US8737295B2 (en) 2007-11-16 2014-05-27 Qualcomm Incorporated Sector identification using sector parameters signatures
US8848656B2 (en) 2007-11-16 2014-09-30 Qualcomm Incorporated Utilizing broadcast signals to convey restricted association information
US9603062B2 (en) 2007-11-16 2017-03-21 Qualcomm Incorporated Classifying access points using pilot identifiers
EP2103614A1 (de) * 2008-03-18 2009-09-23 Santhera Pharmaceuticals (Schweiz) AG Substituiertes Imidazopyrimidin, Imidazopyrazin und Imidazopyridazinderivate als Melanocortin-4-Rezeptormodulatoren
US8588773B2 (en) 2008-08-04 2013-11-19 Qualcomm Incorporated System and method for cell search and selection in a wireless communication system
UA99555C2 (en) 2008-11-12 2012-08-27 Элджи Лайф Саенсез Лтд. Melanocortin receptor agonists
ES2623503T3 (es) * 2009-11-18 2017-07-11 Helsinn Healthcare Sa Composiciones para tratar náuseas y vómitos mediados centralmente
EP2722045B1 (de) 2009-11-18 2016-07-06 Helsinn Healthcare SA Zusammensetzungen zur Behandlung von zentral vermitteltem Unwohlsein und Erbrechen
EP2683699B1 (de) 2011-03-08 2015-06-24 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120052A1 (de) 2011-03-08 2012-09-13 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2012120053A1 (de) 2011-03-08 2012-09-13 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683705B1 (de) 2011-03-08 2015-04-22 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120056A1 (de) 2011-03-08 2012-09-13 Sanofi Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
CA2995188A1 (en) 2015-08-04 2017-02-09 Astellas Pharma Inc. Piperazine derivative
WO2020087031A1 (en) 2018-10-26 2020-04-30 The Research Foundation For The State University Of New York Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia
KR102838870B1 (ko) 2020-06-09 2025-07-24 화이자 인코포레이티드 멜라노코르틴 4 수용체 길항제로서의 스피로 화합물 및 그의 용도
US20250129048A1 (en) 2021-12-06 2025-04-24 Pfizer Inc. Melanocortin 4 receptor antagonists and uses thereof
WO2025228892A1 (en) 2024-04-30 2025-11-06 Boehringer Ingelheim International Gmbh Monoaryl and hetaryl substituted indazoles and benzimidazoles as sting antagonists and the use thereof as medicament
WO2025228899A1 (en) 2024-04-30 2025-11-06 Boehringer Ingelheim International Gmbh Further heterocyclic compounds as sting antagonists and the use thereof as medicament
WO2025228889A1 (en) 2024-04-30 2025-11-06 Boehringer Ingelheim International Gmbh Monoarylic heterocyclic compounds as sting antagonists and the use thereof as medicament
WO2025228900A1 (en) 2024-04-30 2025-11-06 Boehringer Ingelheim International Gmbh Arylamide substituted indazoles and the use thereof as medicament
US20250333414A1 (en) 2024-04-30 2025-10-30 Boehringer Ingelheim International Gmbh Hetaryl substituted indazoles and benzimidazoles as sting antagonists and the use thereof as medicament
WO2025228902A1 (en) 2024-04-30 2025-11-06 Boehringer Ingelheim International Gmbh Heterocyclic acids as sting antagonists and the use thereof as medicament

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
US5274143A (en) * 1991-07-23 1993-12-28 Hoffmann-La Roche Inc. Process for the preparation of (R)-3-hexyl-5,6-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one and (R)-5,6-dihydro-6-undecyl-2H-pyran-2,4(3H)-dione
FR2692575B1 (fr) * 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
TW381025B (en) * 1993-08-05 2000-02-01 Hoffmann La Roche Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor
US5596106A (en) * 1994-07-15 1997-01-21 Eli Lilly And Company Cannabinoid receptor antagonists
DE4435477A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Cycloalkano-indol- und -azaindol-derivate
US5521186A (en) * 1994-10-27 1996-05-28 Janssen Pharmaceutica N.V. Apolipoprotein-β synthesis inhibitors
BR9509436A (pt) * 1994-10-27 1998-01-06 Janssen Pharmaceutica Nv Inibidores de síntese de apoliproteina-B
WO2000035296A1 (en) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Improved release of medicament active agents from a chewing gum coating
KR100652994B1 (ko) * 1998-09-11 2006-11-30 아방티 파르마 소시에테 아노님 아제티딘 유도체, 이의 제조방법 및 이를 함유하는 약제
FR2789079B3 (fr) * 1999-02-01 2001-03-02 Sanofi Synthelabo Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
AU2002230843B8 (en) 2000-12-14 2007-05-17 Amylin Pharmaceuticals, Llc Peptide YY and peptide YY agonists for treatment of metabolic disorders
ATE341327T1 (de) 2001-02-28 2006-10-15 Merck & Co Inc Acylierte piperidin-derivate als melanocortin-4- rezeptor-agonisten
MXPA03007785A (es) 2001-02-28 2003-12-08 Merck & Co Inc Derivados de piperidina acilados como agonistas del receptor de melanocortina 4.
KR100846614B1 (ko) 2001-03-22 2008-07-16 솔베이 파마슈티칼스 비. 브이 Ｃｂ1-길항 활성을 갖는 4,5-디하이드로-1ｈ-피라졸 유도체
US20050015820A1 (en) 2001-09-24 2005-01-20 Michael Cowley Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
EP1482794A1 (de) 2002-03-06 2004-12-08 Merck & Co., Inc. Verfahren zur behandlung oder vorbeugung von fettleibigkeit
NZ537685A (en) 2002-07-29 2007-06-29 Hoffmann La Roche Novel benzodioxoles
CA2494091C (en) 2002-08-02 2011-02-01 Richard B. Toupence Substituted furo [2,3-b| pyridine derivatives
US7129239B2 (en) 2002-10-28 2006-10-31 Pfizer Inc. Purine compounds and uses thereof
MY134457A (en) 2002-11-22 2007-12-31 Merck & Co Inc Substituted amides
US7329658B2 (en) 2003-02-06 2008-02-12 Pfizer Inc Cannabinoid receptor ligands and uses thereof
US7141669B2 (en) 2003-04-23 2006-11-28 Pfizer Inc. Cannabiniod receptor ligands and uses thereof
US7145012B2 (en) 2003-04-23 2006-12-05 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
US7151097B2 (en) * 2003-11-07 2006-12-19 Pfizer Inc. Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
GB0402492D0 (en) * 2004-02-04 2004-03-10 Pfizer Ltd Pharmaceutically active compounds
US7649002B2 (en) 2004-02-04 2010-01-19 Pfizer Inc (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
CA2617654A1 (en) * 2005-08-04 2007-02-08 Pfizer Limited Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds
US8592403B2 (en) 2008-08-06 2013-11-26 Pfizer Limited Diazepine and diazocane compounds as MC4 agonists

Also Published As

Publication number Publication date
ECSP088688A (es) 2008-10-31
KR20080095918A (ko) 2008-10-29
RS20080371A (sr) 2009-07-15
EP1989196B1 (de) 2013-02-13
KR101036981B1 (ko) 2011-05-25
HK1126489A1 (en) 2009-09-04
BRPI0708264A2 (pt) 2011-05-24
MX2008010899A (es) 2008-11-27
IL193279A (en) 2012-12-31
DK1989196T3 (da) 2013-04-15
EA200801738A1 (ru) 2008-12-30
WO2007096763A3 (en) 2007-10-18
US20090036459A1 (en) 2009-02-05
AU2007219236B2 (en) 2012-06-21
US8138188B2 (en) 2012-03-20
EP1989196A2 (de) 2008-11-12
MA30228B1 (fr) 2009-02-02
NO20083480L (no) 2008-09-10
CA2642922A1 (en) 2007-08-30
TNSN08337A1 (fr) 2009-12-29
CA2642922C (en) 2011-08-02
IL193279A0 (en) 2009-02-11
AP2008004602A0 (en) 2008-10-31
SG185849A1 (en) 2012-12-28
WO2007096763A2 (en) 2007-08-30
AU2007219236A1 (en) 2007-08-30
CR10219A (es) 2008-09-23
ES2402581T3 (es) 2013-05-06

Similar Documents

Publication Publication Date Title
MEP6808A (xx) Priperidinoilpirodolini agonisti receptora menalokortina tipa 4
UA84208C2 (en) Tetraazabenzo(e)azulene derivatives and analogs thereof
EA200900658A1 (ru) Производные индазолилэфиров или -амидов для лечения расстройств, опосредованных глюкокортиодными рецепторами
TNSN08444A1 (en) Bicyclic derivatives as cetp inhibitors
MX2009008159A (es) Compuestos y composiciones como moduladores de la actividad de gpr119.
GB0625648D0 (en) Compounds
JO2701B1 (en) Vehicles
ATE455110T1 (de) 11-beta-hydroxysteroid-dehydrogenase-1-hemmer
JO2686B1 (en) Vehicles
DK2021336T3 (da) 11-beta-hydroxysteroid-dehydrogenase-1-inhibitorer
MX2008012400A (es) Azolopirimidinas como inhibidores de actividad de cannabinoide 1.
TW200732313A (en) Oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators
MY143581A (en) Carboxamide derivatives as muscarinic receptor antagonists
ZA200810031B (en) 1,3-disubstituted 4-methyl-1H-pyrrole-2-carboxamides and their use for the manufacture of medicaments
MX2010003440A (es) Compuesto inhibidor de glicogeno fosforilasa y composicion farmaceutica del mismo.
MA32945B1 (fr) Tétrahydropyrane spiro pyrrolidinone et pipéridinone substituées, leur préparation et leur utilisation thérapeutique
TW200734323A (en) 3-Aminocyclopentanecarboxamides as modulators of chemokine receptors
TW200745122A (en) New compounds I
MY149973A (en) 3-carboxypropyl-aminotetralin derivatives as mu opioid receptor antagonists
DE602007007934D1 (en) Imidazoazephinonverbindungen
GB0621805D0 (en) Organic compounds
GB0513886D0 (en) Novel compounds
MX2007010572A (es) Compuestos de cinolina y su uso como moduladores de receptor x de higado.
UA102508C2 (ru) Производные индола как агонисты рецептора s1p1
TW200716090A (en) Inhibitors of soluble adenylate cyclase